Evaluation of Soluble ST2 and Galectin-3 Levels in Patients with Heart Failure.

sST2 and galectin-3 levels were higher in patients with HFrEF and HFmrEF compared to the control group, and these markers increased as EF decreased. However, these markers did not differ between patients with HFpEF and the control group.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-01-21
DOI
https://doi.org/10.5543/tkda.2025.44679
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Soluble ST2 and Galectin-3 Levels in Patients with Heart Failure.

Recep Demirbağ, Kenan Toprak, Mustafa Beğenç Taşcanov, Zülkif Tanrıverdi et al.
PubMed
Galectins and Cancer Biology
article

Evaluation of Soluble ST2 and Galectin-3 Levels in Patients with Heart Failure.

Recep Demirbağ, Kenan Toprak, Mustafa Beğenç Taşcanov, Zülkif Tanrıverdi, İbrahim Halil Altıparmak, Mustafa Çetın, İsmail Koyuncu, Halil Fedai, Asuman Biçer Yeşilay
article en

Abstract

sST2 and galectin-3 levels were higher in patients with HFrEF and HFmrEF compared to the control group, and these markers increased as EF decreased. However, these markers did not differ between patients with HFpEF and the control group.

PubMed
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi (TR), Harran University (TR)
Good health and well-being
Openalex Percentile: Top 82%
Galectins and Cancer Biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.